Orchestra Biomed Holdings Inc Share Price Today: Live Updates & Key Insights

Orchestra Biomed Holdings Inc share price today is $4.59, up 0%. The stock opened at $4.72 against the previous close of $4.64, with an intraday high of $4.72 and low of $4.49.

Orchestra Biomed Holdings Inc Share Price Chart

Orchestra Biomed Holdings Inc

us-stock
To Invest in {{usstockname}}
us-stock

Orchestra Biomed Holdings Inc Share Price Performance

$4.59 0(0%) OBIO at 23 Mar 2026 02:34 PM Biotechnology
Lowest Today 4.49
Highest Today 4.72
Today’s Open 4.72
Prev. Close 4.64
52 Week High 5.42
52 Week Low 2.20
Day’s Range: Low 4.49 High 4.72
52-Week Range: Low 2.20 High 5.42
1 day return -
1 Week return +2.53
1 month return +15.34
3 month return +5.42
6 month return +88.66
1 year return +3.55
3 year return -70.2
5 year return -57.9
10 year return -

Orchestra Biomed Holdings Inc Institutional Holdings

Orchestra Biomed Holdings Inc Market Status

Strong Buy: 4

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Orchestra Biomed Holdings Inc Fundamentals

Market Cap 271.54 M

PB Ratio 5.0415

PE Ratio 0.0

Enterprise Value 180.98 M

Total Assets 114.86 M

Volume 474947

Orchestra Biomed Holdings Inc Company Financials

Annual Revenue FY23:2760000 2.8M, FY21:-782000 -0.8M, FY20:5703000 5.7M

Annual Profit FY23:2430500 2.4M, FY21:-981000 -1.0M, FY20:5558000 5.6M

Annual Net worth FY23:-49120000 -49.1M, FY21:-23014000 -23.0M, FY20:-21355000 -21.4M

Quarterly Revenue Q3/2025:861000 0.9M, Q2/2025:836000 0.8M, Q1/2025:868000 0.9M, Q3/2024:987000 1.0M, Q2/2024:778000 0.8M

Quarterly Profit Q3/2025:812000 0.8M, Q2/2025:790000 0.8M, Q1/2025:824000 0.8M, Q3/2024:919000 0.9M, Q2/2024:734000 0.7M

Quarterly Net worth Q3/2025:-20828000 -20.8M, Q2/2025:-19363000 -19.4M, Q1/2025:-18755000 -18.8M, Q3/2024:-15426000 -15.4M, Q2/2024:-15980000 -16.0M

About Orchestra Biomed Holdings Inc & investment objective

Company Information Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications, such as urology or osteoarthritis; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral vascular disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.

Organisation Biotechnology

Employees 86

Industry Biotechnology

CEO Mr. David P. Hochman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Orchestra Biomed Holdings Inc FAQs

What is the share price of Orchestra Biomed Holdings Inc today?

The current share price of Orchestra Biomed Holdings Inc is $4.59.

Can I buy Orchestra Biomed Holdings Inc shares in India?

Yes, Indian investors can buy Orchestra Biomed Holdings Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Orchestra Biomed Holdings Inc shares in India?

You can easily invest in Orchestra Biomed Holdings Inc shares from India by:

Can I buy fractional shares of Orchestra Biomed Holdings Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Orchestra Biomed Holdings Inc?

Orchestra Biomed Holdings Inc has a market cap of $271.54 M.

In which sector does Orchestra Biomed Holdings Inc belong?

Orchestra Biomed Holdings Inc operates in the Biotechnology sector.

What documents are required to invest in Orchestra Biomed Holdings Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Orchestra Biomed Holdings Inc?

The PE ratio of Orchestra Biomed Holdings Inc is N/A and the PB ratio is 5.04.